Early detection of cancer significantly improves treatment outcomes, but current technologies have limitations. Screening tests like mammograms and colonoscopies are invasive and can be uncomfortable, deterring some people from getting screened. Additionally, these tests are not always accurate and can lead to overdiagnosis or missed cancers. Liquid biopsies, which detect cancer through blood samples, are a promising area of research but are not yet reliable enough for widespread clinical use.